According to Latest Study , the global market for Antiallergics Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Antiallergics Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Antiallergics Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Antihistamines segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospital Pharmacy has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2030.
The global key manufacturers of Antiallergics Drugs include Akorn, Pfizer, GSK plc, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Sanofi, Boehringer Ingelheim International GmbH and AstraZeneca, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Antiallergics Drugs. Report Highlights:
(1) Global Antiallergics Drugs market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Antiallergics Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Antiallergics Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Antiallergics Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Antiallergics Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Antiallergics Drugs, capacity, production and trends.
(7) Antiallergics Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Antihistamines
Corticosteroids
Epinephrine
Allergen Immunotherapy
Decongestants
Others
Market segment by application, can be divided into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market segment by players, this report covers
Akorn
Pfizer
GSK plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Sanofi
Boehringer Ingelheim International GmbH
AstraZeneca
Johnson & Johnson Private
Bayer AG
Merck & Co.
Prestige Consumer Healthcare
F. Hoffmann-La Roche
Bristol-Myers Squibb Company
Almirall
Zenomed Healthcare Private
Cadila Pharmaceuticals
1 Market Overview
1.1 Antiallergics Drugs Definition
1.2 Global Antiallergics Drugs Market Size and Forecast
1.2.1 By Revenue, Global Antiallergics Drugs Market Size, 2019-2030
1.2.2 By Sales Volume, Global Antiallergics Drugs Market Size, 2019-2030
1.2.3 Global Antiallergics Drugs Price Trend, 2019-2030
1.3 China Antiallergics Drugs Market Size and Forecast
1.3.1 By Revenue, China Antiallergics Drugs Market Size, 2019-2030
1.3.2 By Sales Volume, China Antiallergics Drugs Market Size, 2019-2030
1.3.3 China Antiallergics Drugs Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Antiallergics Drugs Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Antiallergics Drugs Share in Global Market, 2019-2030
1.4.3 Antiallergics Drugs Market Size: China VS Global, 2019-2030
1.5 Antiallergics Drugs Market Dynamics
1.5.1 Antiallergics Drugs Market Drivers
1.5.2 Antiallergics Drugs Market Restraints
1.5.3 Antiallergics Drugs Industry Trends
1.5.4 Antiallergics Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Antiallergics Drugs Revenue by Company, 2019-2024
2.2 Global Antiallergics Drugs Sales Volume by Company, 2019-2024
2.3 Global Antiallergics Drugs Price by Company, 2019-2024
2.4 Global Antiallergics Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Antiallergics Drugs Concentration Ratio
2.6 Global Antiallergics Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Antiallergics Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Antiallergics Drugs Revenue by Company, 2019-2024
3.2 China Antiallergics Drugs Sales Volume by Company, 2019-2024
3.3 China Antiallergics Drugs Antiallergics Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Antiallergics Drugs Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Antiallergics Drugs Domestic VS Export
3.6 China Market, Antiallergics Drugs Import & Export
3.6.1 China Market, Antiallergics Drugs Import & Export, 2019-2030
3.6.2 China Antiallergics Drugs Import & Export Trends
3.6.3 Main Sources of China Antiallergics Drugs Import
3.6.4 Export Destination of China Antiallergics Drugs
4 Antiallergics Drugs Production by Region
4.1 Global Antiallergics Drugs Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Antiallergics Drugs Manufacturers
4.3 Global Major Manufacturers, Antiallergics Drugs Capacity Expansion and Future Plans
4.4 Global Antiallergics Drugs Capacity by Region
4.5 Global Antiallergics Drugs Production by Region
4.5.1 Global Antiallergics Drugs Production & Forecast by Region, 2019 VS 2023 VS 2030
4.5.2 Global Antiallergics Drugs Production by Region, 2019-2024
4.5.3 Global Antiallergics Drugs Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Antiallergics Drugs Industry Chain
5.2 Antiallergics Drugs Upstream Analysis
5.2.1 Antiallergics Drugs Core Raw Materials
5.2.2 Main Manufacturers of Antiallergics Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Antiallergics Drugs Production Mode
5.6 Antiallergics Drugs Procurement Model
5.7 Antiallergics Drugs Industry Sales Model and Sales Channels
5.7.1 Antiallergics Drugs Sales Model
5.7.2 Antiallergics Drugs Typical Distributors
6 Sights by Type
6.1 Antiallergics Drugs Classification
6.1.1 Antihistamines
6.1.2 Corticosteroids
6.1.3 Epinephrine
6.1.4 Allergen Immunotherapy
6.1.5 Decongestants
6.1.6 Others
6.2 By Type, Global Antiallergics Drugs Market Size & CAGR, 2019 VS 2023 VS 2030
6.3 By Type, Global Antiallergics Drugs Revenue, 2019-2030
6.4 By Type, Global Antiallergics Drugs Sales Volume, 2019-2030
6.5 By Type, Global Antiallergics Drugs Price, 2019-2030
7 Sights by Application
7.1 Antiallergics Drugs Segment by Application
7.1.1 Hospital Pharmacy
7.1.2 Retail Pharmacy
7.1.3 Online Pharmacy
7.2 By Application, Global Antiallergics Drugs Market Size & CAGR, 2019 VS 2023 VS 2030
7.3 By Application, Global Antiallergics Drugs Revenue, 2019-2030
7.4 By Application, Global Antiallergics Drugs Sales Volume, 2019-2030
7.5 By Application, Global Antiallergics Drugs Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Antiallergics Drugs Market Size, 2019 VS 2023 VS 2030
8.2 By Region, Global Antiallergics Drugs Revenue, 2019-2030
8.3 By Region, Global Antiallergics Drugs Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Antiallergics Drugs Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Antiallergics Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Antiallergics Drugs Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Antiallergics Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Antiallergics Drugs Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Antiallergics Drugs Market Size Market Share
8.7 South America
8.7.1 South America Antiallergics Drugs Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Antiallergics Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Antiallergics Drugs Market Size & CAGR,2019 VS 2023 VS 2030
9.2 By Country, Global Antiallergics Drugs Revenue, 2019-2030
9.3 By Country, Global Antiallergics Drugs Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Antiallergics Drugs Market Size, 2019-2030
9.4.2 By Company, U.S. Antiallergics Drugs Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.4.4 By Application, U.S. Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.5 Europe
9.5.1 Europe Antiallergics Drugs Market Size, 2019-2030
9.5.2 By Company, Europe Antiallergics Drugs Sales Volume Market Share, 2022
9.5.3 By Type, Europe Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.5.4 By Application, Europe Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.6 China
9.6.1 China Antiallergics Drugs Market Size, 2019-2030
9.6.2 By Company, China Antiallergics Drugs Sales Volume Market Share, 2022
9.6.3 By Type, China Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.6.4 By Application, China Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.7 Japan
9.7.1 Japan Antiallergics Drugs Market Size, 2019-2030
9.7.2 By Company, Japan Antiallergics Drugs Sales Volume Market Share, 2022
9.7.3 By Type, Japan Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.7.4 By Application, Japan Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.8 South Korea
9.8.1 South Korea Antiallergics Drugs Market Size, 2019-2030
9.8.2 By Company, South Korea Antiallergics Drugs Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.8.4 By Application, South Korea Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Antiallergics Drugs Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Antiallergics Drugs Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.9.4 By Application, Southeast Asia Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.10 India
9.10.1 India Antiallergics Drugs Market Size, 2019-2030
9.10.2 By Company, India Antiallergics Drugs Sales Volume Market Share, 2022
9.10.3 By Type, India Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.10.4 By Application, India Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Antiallergics Drugs Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Antiallergics Drugs Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Antiallergics Drugs Market Size, Share, 2023 VS 2030
9.11.4 By Application, Middle East & Asia Antiallergics Drugs Market Size, Share, 2023 VS 2030
10 Manufacturers Profile
10.1 Akorn
10.1.1 Akorn Company Information, Head Office, Market Area and Industry Position
10.1.2 Akorn Antiallergics Drugs Models, Specifications and Application
10.1.3 Akorn Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Akorn Company Profile and Main Business
10.1.5 Akorn Recent Developments
10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.2.2 Pfizer Antiallergics Drugs Models, Specifications and Application
10.2.3 Pfizer Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments
10.3 GSK plc
10.3.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.3.2 GSK plc Antiallergics Drugs Models, Specifications and Application
10.3.3 GSK plc Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 GSK plc Company Profile and Main Business
10.3.5 GSK plc Recent Developments
10.4 Novartis AG
10.4.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.4.2 Novartis AG Antiallergics Drugs Models, Specifications and Application
10.4.3 Novartis AG Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Novartis AG Company Profile and Main Business
10.4.5 Novartis AG Recent Developments
10.5 Mylan N.V.
10.5.1 Mylan N.V. Company Information, Head Office, Market Area and Industry Position
10.5.2 Mylan N.V. Antiallergics Drugs Models, Specifications and Application
10.5.3 Mylan N.V. Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Mylan N.V. Company Profile and Main Business
10.5.5 Mylan N.V. Recent Developments
10.6 Teva Pharmaceutical Industries
10.6.1 Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
10.6.2 Teva Pharmaceutical Industries Antiallergics Drugs Models, Specifications and Application
10.6.3 Teva Pharmaceutical Industries Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Teva Pharmaceutical Industries Company Profile and Main Business
10.6.5 Teva Pharmaceutical Industries Recent Developments
10.7 Sanofi
10.7.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.7.2 Sanofi Antiallergics Drugs Models, Specifications and Application
10.7.3 Sanofi Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Sanofi Company Profile and Main Business
10.7.5 Sanofi Recent Developments
10.8 Boehringer Ingelheim International GmbH
10.8.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
10.8.2 Boehringer Ingelheim International GmbH Antiallergics Drugs Models, Specifications and Application
10.8.3 Boehringer Ingelheim International GmbH Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.8.5 Boehringer Ingelheim International GmbH Recent Developments
10.9 AstraZeneca
10.9.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.9.2 AstraZeneca Antiallergics Drugs Models, Specifications and Application
10.9.3 AstraZeneca Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 AstraZeneca Company Profile and Main Business
10.9.5 AstraZeneca Recent Developments
10.10 Johnson & Johnson Private
10.10.1 Johnson & Johnson Private Company Information, Head Office, Market Area and Industry Position
10.10.2 Johnson & Johnson Private Antiallergics Drugs Models, Specifications and Application
10.10.3 Johnson & Johnson Private Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Johnson & Johnson Private Company Profile and Main Business
10.10.5 Johnson & Johnson Private Recent Developments
10.11 Bayer AG
10.11.1 Bayer AG Company Information, Head Office, Market Area and Industry Position
10.11.2 Bayer AG Antiallergics Drugs Models, Specifications and Application
10.11.3 Bayer AG Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 Bayer AG Company Profile and Main Business
10.11.5 Bayer AG Recent Developments
10.12 Merck & Co.
10.12.1 Merck & Co. Company Information, Head Office, Market Area and Industry Position
10.12.2 Merck & Co. Antiallergics Drugs Models, Specifications and Application
10.12.3 Merck & Co. Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Merck & Co. Company Profile and Main Business
10.12.5 Merck & Co. Recent Developments
10.13 Prestige Consumer Healthcare
10.13.1 Prestige Consumer Healthcare Company Information, Head Office, Market Area and Industry Position
10.13.2 Prestige Consumer Healthcare Antiallergics Drugs Models, Specifications and Application
10.13.3 Prestige Consumer Healthcare Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Prestige Consumer Healthcare Company Profile and Main Business
10.13.5 Prestige Consumer Healthcare Recent Developments
10.14 F. Hoffmann-La Roche
10.14.1 F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position
10.14.2 F. Hoffmann-La Roche Antiallergics Drugs Models, Specifications and Application
10.14.3 F. Hoffmann-La Roche Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 F. Hoffmann-La Roche Company Profile and Main Business
10.14.5 F. Hoffmann-La Roche Recent Developments
10.15 Bristol-Myers Squibb Company
10.15.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
10.15.2 Bristol-Myers Squibb Company Antiallergics Drugs Models, Specifications and Application
10.15.3 Bristol-Myers Squibb Company Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.15.5 Bristol-Myers Squibb Company Recent Developments
10.16 Almirall
10.16.1 Almirall Company Information, Head Office, Market Area and Industry Position
10.16.2 Almirall Antiallergics Drugs Models, Specifications and Application
10.16.3 Almirall Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.16.4 Almirall Company Profile and Main Business
10.16.5 Almirall Recent Developments
10.17 Zenomed Healthcare Private
10.17.1 Zenomed Healthcare Private Company Information, Head Office, Market Area and Industry Position
10.17.2 Zenomed Healthcare Private Antiallergics Drugs Models, Specifications and Application
10.17.3 Zenomed Healthcare Private Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.17.4 Zenomed Healthcare Private Company Profile and Main Business
10.17.5 Zenomed Healthcare Private Recent Developments
10.18 Cadila Pharmaceuticals
10.18.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.18.2 Cadila Pharmaceuticals Antiallergics Drugs Models, Specifications and Application
10.18.3 Cadila Pharmaceuticals Antiallergics Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.18.4 Cadila Pharmaceuticals Company Profile and Main Business
10.18.5 Cadila Pharmaceuticals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Antiallergics Drugs Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Antiallergics Drugs Market Restraints
Table 3. Antiallergics Drugs Market Trends
Table 4. Antiallergics Drugs Industry Policy
Table 5. Global Antiallergics Drugs Revenue by Company, 2019-2024, US$ million
Table 6. Global Antiallergics Drugs Revenue Market Share by Company, 2019-2024
Table 7. Global Antiallergics Drugs Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Antiallergics Drugs Sales Volume Market Share by Company, 2019-2024
Table 9. Global Antiallergics Drugs Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Antiallergics Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Antiallergics Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Antiallergics Drugs Manufacturers Product Type
Table 13. China Antiallergics Drugs Revenue by Company, 2019-2024, US$ million
Table 14. China Antiallergics Drugs Revenue Market Share by Company, 2019-2024
Table 15. China Antiallergics Drugs Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Antiallergics Drugs Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Antiallergics Drugs Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Antiallergics Drugs Import & Export Trends
Table 19. Main Sources of China Antiallergics Drugs Import
Table 20. Export Destination of China Antiallergics Drugs
Table 21. Global Headquarters and Manufacturing Base of Antiallergics Drugs Manufacturers
Table 22. Global Major Manufacturers, Antiallergics Drugs Capacity Expansion and Future Plans
Table 23. Global Antiallergics Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Antiallergics Drugs Production by Region, 2019-2024, (K Units)
Table 25. Global Antiallergics Drugs Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Antiallergics Drugs Upstream (Raw Materials)
Table 27. Global Antiallergics Drugs Typical Customers
Table 28. Antiallergics Drugs Typical Distributors
Table 29. By Type, Global Antiallergics Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Antiallergics Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Antiallergics Drugs Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Antiallergics Drugs Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Antiallergics Drugs Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Antiallergics Drugs Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Antiallergics Drugs Revenue Market Share, 2019-2030
Table 37. By Country, Global Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Antiallergics Drugs Sales Volume Market Share, 2019-2030
Table 39. Akorn Company Information, Head Office, Market Area and Industry Position
Table 40. Akorn Antiallergics Drugs Models, Specifications and Application
Table 41. Akorn Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. Akorn Company Profile and Main Business
Table 43. Akorn Recent Developments
Table 44. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 45. Pfizer Antiallergics Drugs Models, Specifications and Application
Table 46. Pfizer Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Pfizer Company Profile and Main Business
Table 48. Pfizer Recent Developments
Table 49. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 50. GSK plc Antiallergics Drugs Models, Specifications and Application
Table 51. GSK plc Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. GSK plc Company Profile and Main Business
Table 53. GSK plc Recent Developments
Table 54. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 55. Novartis AG Antiallergics Drugs Models, Specifications and Application
Table 56. Novartis AG Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Novartis AG Company Profile and Main Business
Table 58. Novartis AG Recent Developments
Table 59. Mylan N.V. Company Information, Head Office, Market Area and Industry Position
Table 60. Mylan N.V. Antiallergics Drugs Models, Specifications and Application
Table 61. Mylan N.V. Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Mylan N.V. Company Profile and Main Business
Table 63. Mylan N.V. Recent Developments
Table 64. Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
Table 65. Teva Pharmaceutical Industries Antiallergics Drugs Models, Specifications and Application
Table 66. Teva Pharmaceutical Industries Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Teva Pharmaceutical Industries Company Profile and Main Business
Table 68. Teva Pharmaceutical Industries Recent Developments
Table 69. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 70. Sanofi Antiallergics Drugs Models, Specifications and Application
Table 71. Sanofi Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Sanofi Company Profile and Main Business
Table 73. Sanofi Recent Developments
Table 74. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position
Table 75. Boehringer Ingelheim International GmbH Antiallergics Drugs Models, Specifications and Application
Table 76. Boehringer Ingelheim International GmbH Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 78. Boehringer Ingelheim International GmbH Recent Developments
Table 79. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 80. AstraZeneca Antiallergics Drugs Models, Specifications and Application
Table 81. AstraZeneca Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. AstraZeneca Company Profile and Main Business
Table 83. AstraZeneca Recent Developments
Table 84. Johnson & Johnson Private Company Information, Head Office, Market Area and Industry Position
Table 85. Johnson & Johnson Private Antiallergics Drugs Models, Specifications and Application
Table 86. Johnson & Johnson Private Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Johnson & Johnson Private Company Profile and Main Business
Table 88. Johnson & Johnson Private Recent Developments
Table 89. Bayer AG Company Information, Head Office, Market Area and Industry Position
Table 90. Bayer AG Antiallergics Drugs Models, Specifications and Application
Table 91. Bayer AG Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. Bayer AG Company Profile and Main Business
Table 93. Bayer AG Recent Developments
Table 94. Merck & Co. Company Information, Head Office, Market Area and Industry Position
Table 95. Merck & Co. Antiallergics Drugs Models, Specifications and Application
Table 96. Merck & Co. Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Merck & Co. Company Profile and Main Business
Table 98. Merck & Co. Recent Developments
Table 99. Prestige Consumer Healthcare Company Information, Head Office, Market Area and Industry Position
Table 100. Prestige Consumer Healthcare Antiallergics Drugs Models, Specifications and Application
Table 101. Prestige Consumer Healthcare Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Prestige Consumer Healthcare Company Profile and Main Business
Table 103. Prestige Consumer Healthcare Recent Developments
Table 104. F. Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position
Table 105. F. Hoffmann-La Roche Antiallergics Drugs Models, Specifications and Application
Table 106. F. Hoffmann-La Roche Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. F. Hoffmann-La Roche Company Profile and Main Business
Table 108. F. Hoffmann-La Roche Recent Developments
Table 109. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position
Table 110. Bristol-Myers Squibb Company Antiallergics Drugs Models, Specifications and Application
Table 111. Bristol-Myers Squibb Company Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. Bristol-Myers Squibb Company Company Profile and Main Business
Table 113. Bristol-Myers Squibb Company Recent Developments
Table 114. Almirall Company Information, Head Office, Market Area and Industry Position
Table 115. Almirall Antiallergics Drugs Models, Specifications and Application
Table 116. Almirall Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 117. Almirall Company Profile and Main Business
Table 118. Almirall Recent Developments
Table 119. Zenomed Healthcare Private Company Information, Head Office, Market Area and Industry Position
Table 120. Zenomed Healthcare Private Antiallergics Drugs Models, Specifications and Application
Table 121. Zenomed Healthcare Private Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 122. Zenomed Healthcare Private Company Profile and Main Business
Table 123. Zenomed Healthcare Private Recent Developments
Table 124. Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 125. Cadila Pharmaceuticals Antiallergics Drugs Models, Specifications and Application
Table 126. Cadila Pharmaceuticals Antiallergics Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 127. Cadila Pharmaceuticals Company Profile and Main Business
Table 128. Cadila Pharmaceuticals Recent Developments
List of Figure
Figure 1. Antiallergics Drugs Picture
Figure 2. By Revenue, Global Antiallergics Drugs Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Antiallergics Drugs Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Antiallergics Drugs Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Antiallergics Drugs Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Antiallergics Drugs Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Antiallergics Drugs Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Antiallergics Drugs Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Antiallergics Drugs Share of Global Market, 2019-2030
Figure 10. Global Antiallergics Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Antiallergics Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Antiallergics Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Antiallergics Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Antiallergics Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Antiallergics Drugs Domestic VS Export, 2022
Figure 16. Global Antiallergics Drugs Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Antiallergics Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Antiallergics Drugs Production Market Share & Forecast by Region, 2019-2030
Figure 19. Antiallergics Drugs Industry Chain
Figure 20. Antiallergics Drugs Procurement Model
Figure 21. Antiallergics Drugs Sales Model
Figure 22. Antiallergics Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Antihistamines
Figure 24. Corticosteroids
Figure 25. Epinephrine
Figure 26. Allergen Immunotherapy
Figure 27. Decongestants
Figure 28. Others
Figure 29. By Type, Global Antiallergics Drugs Revenue, 2019-2030, US$ Million
Figure 30. By Type, Global Antiallergics Drugs Revenue Market Share, 2019-2030
Figure 31. By Type, Global Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 32. By Type, Global Antiallergics Drugs Sales Volume Market Share, 2019-2030
Figure 33. By Type, Global Antiallergics Drugs Price, 2019-2030, (US$/Unit)
Figure 34. Hospital Pharmacy
Figure 35. Retail Pharmacy
Figure 36. Online Pharmacy
Figure 37. By Application, Global Antiallergics Drugs Revenue, 2019-2030, US$ Million
Figure 38. By Application, Global Antiallergics Drugs Revenue Market Share, 2019-2030
Figure 39. By Application, Global Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 40. By Application, Global Antiallergics Drugs Sales Volume Market Share, 2019-2030
Figure 41. By Application, Global Antiallergics Drugs Price, 2019-2030, (US$/Unit)
Figure 42. By Region, Global Antiallergics Drugs Revenue Market Share, 2019-2030
Figure 43. By Region, Global Antiallergics Drugs Sales Volume Market Share, 2019-2030
Figure 44. North America Antiallergics Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 45. By Country, North America Antiallergics Drugs Revenue Market Share, 2022
Figure 46. Europe Antiallergics Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 47. By Country, Europe Antiallergics Drugs Revenue Market Share, 2022
Figure 48. Asia Pacific Antiallergics Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 49. By Country/Region, Asia Pacific Antiallergics Drugs Revenue Market Share, 2022
Figure 50. South America Antiallergics Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 51. By Country, South America Antiallergics Drugs Revenue Market Share, 2022
Figure 52. Middle East & Africa Antiallergics Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 53. U.S. Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 54. By Company, U.S. Antiallergics Drugs Market Share, 2022
Figure 55. By Type, U.S. Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, U.S. Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 57. Europe Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 58. By Company, Europe Antiallergics Drugs Market Share, 2022
Figure 59. By Type, Europe Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, Europe Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 61. China Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 62. By Company, China Antiallergics Drugs Market Share, 2022
Figure 63. By Type, China Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, China Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 65. Japan Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 66. By Company, Japan Antiallergics Drugs Market Share, 2022
Figure 67. By Type, Japan Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, Japan Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 69. South Korea Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 70. By Company, South Korea Antiallergics Drugs Market Share, 2022
Figure 71. By Type, South Korea Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, South Korea Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 73. Southeast Asia Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 74. By Company, Southeast Asia Antiallergics Drugs Market Share, 2022
Figure 75. By Type, Southeast Asia Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, Southeast Asia Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 77. India Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 78. By Company, India Antiallergics Drugs Market Share, 2022
Figure 79. By Type, India Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, India Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 81. Middle East & Asia Antiallergics Drugs Sales Volume, 2019-2030, (K Units)
Figure 82. By Company, Middle East & Asia Antiallergics Drugs Market Share, 2022
Figure 83. By Type, Middle East & Asia Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 84. By Application, Middle East & Asia Antiallergics Drugs Sales Volume Market Share, 2022 VS 2029
Figure 85. Research Methodology
Figure 86. Breakdown of Primary Interviews
Figure 87. Bottom-up Approaches
Figure 88. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|